Carillon Tower Advisers’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$3.36M Sell
72,136
-3,700
-5% -$173K 0.02% 439
2020
Q3
$3.22M Buy
75,836
+25,540
+51% +$1.12M 0.04% 377
2020
Q2
$2.41M Sell
50,296
-1,200
-2% -$59.9K 0.02% 425
2020
Q1
$2.37M Sell
51,496
-5,500
-10% -$276K 0.02% 392
2019
Q4
$3.42M Sell
56,996
-1,900
-3% -$113K 0.02% 423
2019
Q3
$3.33M Sell
58,896
-500
-0.8% -$28.1K 0.02% 428
2019
Q2
$3.31M Buy
59,396
+5,900
+11% +$308K 0.02% 428
2019
Q1
$2.7M Buy
53,496
+300
+0.6% +$13.3K 0.02% 434
2018
Q4
$2.14M Buy
53,196
+10,700
+25% +$551K 0.02% 428
2018
Q3
$2.95M Buy
+42,496
New +$3.22M 0.02% 398

Other funds holding EGRX